BlackRock, Inc. 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
BLACKROCK INC BLK |
18,482,795 14.300% |
703,042 (+3.95%) |
Filing |
| 2024-01-23 4:13 pm Purchase |
2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
BLACKROCK INC BLK |
17,779,753 13.100% |
2,944,538 (+19.85%) |
Filing |
| 2023-05-05 11:52 am Purchase |
2023-04-30 | 13G | Cytek Biosciences, Inc. CTKB |
BLACKROCK INC BLK |
14,835,215 10.900% |
6,467,608 (+77.29%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
BLACKROCK INC BLK |
8,367,607 6.200% |
8,367,607 (New Position) |
Filing |